These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6455803)

  • 1. In vitro analysis of immune reactivity in ALS-treated, bone marrow injected mice bearing enhanced skin allografts.
    Maki T; Gottschalk R; Homsy FN; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):596-8. PubMed ID: 6455803
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
    Maki T; Gottschalk R; Wood ML; Monaco AP
    J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow cells that prolong graft survival in ALS-treated mice: suppressor activity in mixed cell culture.
    De Fazio SR; Monaco AP; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):228-30. PubMed ID: 2523127
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ; Wood ML; Pompei R; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific unresponsiveness to skin allografts in mice. IV. Immunological reactivity of mice treated with liver extracts, Bordetella pertussis, and antilymphocyte serum.
    Brooks CG; Brent L; Kilshaw PJ; New RR; Pinto M
    Transplantation; 1975 Feb; 19(2):134-44. PubMed ID: 235163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
    Gozzo JJ; Litvin DA; Bhatnagar YM; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):592-5. PubMed ID: 7022895
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of antilymphocyte globulin for leukemia induction in mice.
    Radzikowski C; Szkudlarek J; Czarnomska A; Steuden J; Krajewski L
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):697-711. PubMed ID: 793567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion.
    Wood ML; Gozzo JJ; Heppner G; Monaco AP
    Transplant Proc; 1972 Sep; 4(3):383-9. PubMed ID: 4263511
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of allograft reactivity in vitro and in vivo, by Fab fragments obtained from ALG.
    Gallagher MT; Richie ER; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):869-72. PubMed ID: 4144466
    [No Abstract]   [Full Text] [Related]  

  • 13. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 17. Workshop summary on genetic determinants of cell-mediated immune reactions in the mouse.
    Festenstein H; Démant P
    Transplant Proc; 1973 Dec; 5(4):1321-7. PubMed ID: 4149543
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific unresponsiveness to skin allografts in mice. II. The mechanism of unresponsiveness induced by tissue extracts and antilymphocytic serum.
    Kilshaw PJ; Brent L; Thomas AV
    Transplantation; 1974 Jan; 17(1):57-69. PubMed ID: 4148889
    [No Abstract]   [Full Text] [Related]  

  • 19. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of suppressor T cells by antilymphocyte serum treatment in mice.
    Maki T; Simpson M; Monaco AP
    Transplantation; 1982 Dec; 34(6):376-81. PubMed ID: 6186056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.